acalabrutinib,axicabtagene ciloleucel
astrazeneca,gilead
['axicel', 'thanks', 'acalabrutinib']
 thanks for reading
axicel indeed showed an os benefit, the data having been published/presented since the poster was made acalabrutinib didn t show os benefit in ascend or elevate as i recall
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem